Development, Regulatory, & Outcomes (DRO) Network
- Enhance communication, cross-training and collaborations among members from multiple sectors including industry, government, and academia.
- Apply principles of clinical pharmacology in the continuum of drug development, regulation, and post-marketing research and surveillance, as well as safe and effective utilization of medicines.
Upcoming Community Webinars
ASCPT Webinar presented by the Special Populations (SPO) Community and Regulatory Science (RS) Community
Title: Pediatric Master Protocols: Clinical Pharmacology Challenges and Opportunities
Date and Time: Monday, October 7, 2019, 1:00 pm ET
Speakers and Panelists: Luna Musib, PhD, Elimika Pfuma Fletcher, PharmD, PhD, and Nita Seibel, MD
Moderators: Anuradha Ramamoorthy, PhD
Description: This special session will focus on opportunities, considerations and challenges related to pediatric master protocols. The speakers will discuss pharmacogenomic and other clinical pharmacology considerations for master protocols. Examples of pediatric master protocols will be highlighted. The pharmacogenomic discussion will highlight considerations for patient selection and treatment allocation based on molecular subsets of disease. The session will also include a moderated panel discussion, including a clinician involved in the NCI Pediatric MATCH trial.
Registration Link: https://register.gotowebinar.com/#register/4299107357330724867
Robin O'Connor-Semmes, PharmD, PhD
Anuradha Ramamoorthy, PhD
Network Vice Chair
Donald L. Heald, PhD
Network Past Chair